La vendita allo scoperto per Centessa Pharmaceuticals dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Centessa Pharmaceuticals. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Centessa Pharmaceuticals (NASDAQ:CNTA) Azioni, Report sulle vendite allo scoperto

Centessa Pharmaceuticals

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals PLC

Cryptocurrency analysts are forecasting a significant shift in market dynamics, suggesting Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recent dominance could decline in favor of alternative <a href="https://www.benzinga.com/24/11/42028334/bitcoin-ethereum-dogecoin-slip-as-feds-hawkish-stance-tempers-rally-analyst-expects-btc-to-reach-100k-before-new-year">cryptocurrencies by the end of this month</a>.
What Happened: Leading cryptocurrency trader Milkybull predicts a &#8220;violent decline&#8221; in Bitcoin&#8217;s market dominance next month, projecting an &#8220;altseason&#8221; that could extend through March. &#8220;It&#8217;s going to get wild for the next few months,&#8221; Milkybull posted on X, formerly Twitter.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bitcoin dominance violent declines begin next month. This perfectly coincides with our previous projection that <a href="https://twitter.com/hashtag/ALTSEASON?src=hash&amp;ref_src=twsrc%5Etfw">#ALTSEASON</a> will begin late this month and end in March 2025. It&#39;s going to get wild for the next few months. <a href="https://t.co/j2qMKexeXU">pic.twitter.com/j2qMKexeXU</a>
&mdash; Mikybull &#x1f402;Crypto (@MikybullCrypto) <a href="https://twitter.com/MikybullCrypto/status/1858083910183419915?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Technical analyst Ash Crypto echoed similar sentiments, citing that the altcoin market cap&#8217;s two-week MACD indicator approaches a &#8220;golden cross,&#8221; a pattern not seen since 2023. &#8220;Last time it happened, altcoin market cap pumped 300%,&#8221; Ash noted, predicting &#8220;the biggest altseason&#8221; within 4-6 weeks.
The MACD, or Moving Average Convergence/Divergence indicator, is a technical indicator that is used to trade based on trends.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">THE BIGGEST ALTSEASON WILL START WITHIN 4-6 WEEKS &#x1f6a8; ALTCOIN MCAP 2W MACD IS APPROACHING A GOLDEN CROSS FOR THE FIRST TIME SINCE 2023 LAST TIME IT HAPPENED, ALTCOIN MCAP PUMPED 300% BE READY FOR A 100X ALTSEASON <a href="https://t.co/OV6RiHhhlD">pic.twitter.com/OV6RiHhhlD</a>
&mdash; Ash Crypto (@Ashcryptoreal) <a href="https://twitter.com/Ashcryptoreal/status/1858088960876036531?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42028720/gita-gopinath-of-imf-alarmed-by-crypto-and-ai-energy-use-says-share-expected-to-match-japans-current-power-consumption-in-just-3-years">Gita Gopinath Of IMF Alarmed By Crypto And AI Energy Use, Says Share Expected To Match Japan&#8217;s Current Power Consumption In Just 3 Years</a>
Why It Matters: Altcoin Season occurs when 75% of alternative cryptocurrencies outperform Bitcoin. Several major altcoins have already shown momentum, with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), and Polkadot (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/dot/usd">DOT</a>) each gaining over 10% in the past week.
Meanwhile, Bitcoin continues its strong performance, trading at $91,648.28, marking a 34% increase over the past month. However, analysts suggest this growth might temporarily <a href="https://www.benzinga.com/24/11/42028334/bitcoin-ethereum-dogecoin-slip-as-feds-hawkish-stance-tempers-rally-analyst-expects-btc-to-reach-100k-before-new-year">slow as investors rotate into altcoins</a>.
The timing of these predictions coincides with Bitcoin&#8217;s recent all-time highs and the growing institutional adoption of cryptocurrencies, particularly following the approval of spot Bitcoin ETFs in January.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42028334/bitcoin-ethereum-dogecoin-slip-as-feds-hawkish-stance-tempers-rally-analyst-expects-btc-to-reach-100k-before-new-year">Bitcoin, Ethereum, Dogecoin Slip As Fed&#8217;s Hawkish Stance Tempers Rally: Analyst Expects BTC To Reach $100K Before New Year</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$ADA

$BTC

$DOGE

$DOT

$ETH

$SOL

$XRP

Bitcoin Dominance Decline Expected Next Month, Analyst Projects 'Altseason' To Peak By March 2025

The Exploration Company (TEC) has announced a successful funding round, raising $160 million to further develop its reusable space capsule, &#8220;Nyx.&#8221; This capsule is designed to transport both astronauts and cargo to space stations.
What Happened: The funding round was led by venture capital firms Balderton Capital and Plural. Additional support came from French Tech Souveraineté and DeepTech &amp; Climate Fonds, initiatives backed by the French and German governments. The Nyx capsule&#8217;s reusability is a key feature, allowing it to re-enter Earth&#8217;s atmosphere and be used for multiple missions, CNBC <a href="https://www.cnbc.com/2024/11/17/the-exploration-company-european-spacex-rival-raises-160-million-for-reusable-sapce-capsule.html">reported</a> on Monday.
Hélène Huby, the founder and CEO of TEC, emphasized the increasing demand for space travel, stating, &#8220;It&#8217;s a big market, and it&#8217;s growing about a bit more than 10% per year.&#8221; 
TEC is currently developing the second version of Nyx, with plans for a launch next year and a final version targeted for 2028. The European Space Agency is partially funding this project. The company has already secured $800 million in contracts, including agreements with Starlab and Axiom Space.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42005034/elon-musk-backs-calls-for-end-to-ev-subsidies-but-former-tesla-exec-warns-of-massive-drop-in-manufacturing-investments-if-trump-follows-through?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Backs Calls For End To EV Subsidies, But Former Tesla Exec Warns Of &#8216;Massive Drop&#8217; In Manufacturing Investments If Trump Follows Through</a>
Why It Matters: The space industry is undergoing a transformation, with private companies playing a pivotal role in what is being <a href="https://www.benzinga.com/partner/general/24/09/41012312/investing-in-the-space-race-whos-set-to-dominate-orbit">termed &#8220;Space Race 2.0.&#8221; </a>This shift began in 2011 when the focus moved to public-private partnerships, with SpaceX emerging as a key player through its Falcon launch vehicle and Dragon spacecraft.
In October, SpaceX, led by CEO Elon Musk, successfully demonstrated <a href="https://www.benzinga.com/news/24/10/41317860/elon-musk-went-from-examining-debris-from-falcon-1-flight-to-spacex-successfully-catching-booster-of">catching a booster propeller</a> for a Starship after it returned to Earth. The launch tower at Starbase caught the propeller with mechanical arms. The key objective of the flight test was to demonstrate the reusability of the Starship's design.
However, Starship <a href="https://www.benzinga.com/general/space/24/11/42025066/elon-musks-spacex-delays-starship-test-flight-next-attempt-now-set-for-tuesday">recently faced a delay </a>in the sixth test flight. This flight, now due Nov. 19, will aim to catch Starship&#8217;s booster back at the launch site as on the previous flight and splash down the upper stage in the Indian Ocean. 
Past Flights:&nbsp;On Starship's&nbsp;<a href="https://www.benzinga.com/news/24/10/41317860/elon-musk-went-from-examining-debris-from-falcon-1-flight-to-spacex-successfully-catching-booster-of" target="_blank" rel="noreferrer noopener">fifth flight test in October</a>, it lifted off from Starbase, and the booster returned to Earth after propelling Starship to space. The booster was subsequently caught by the launch tower at Starbase.
Musk has also been eyeing <a href="https://www.benzinga.com/news/24/09/40770222/elon-musk-sets-2026-for-starships-first-uncrewed-mars-mission-targeting-successful-landing" target="_blank" rel="noreferrer noopener">taking humans to Mars</a>&nbsp;aboard the Starship. In September, he revealed that the first Starship launch to Mars is expected to be in 2026 but it will not carry a crew.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42025317/dogecoin-repeating-its-historical-pattern-says-analyst-meme-coin-set-to-touch-3-by-trumps-inauguration-day-2025?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin &#8216;Repeating Its Historical Pattern,&#8217; Says Analyst: Meme Coin Set To Touch $3 By Trump&#8217;s Inauguration Day 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via TEC

SPACE

Tech

General

SpaceX's European Rival Raises $160M For Reusable Space Capsule

Polish presidential candidate Sławomir Mentzen announced his intention to establish a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve if he emerges victorious in the forthcoming election, joining a growing list of politicians around the world attempting to make cryptocurrency a poll issue.
What Happened: In an X post on Sunday, Mentzen stated that if he is elected as the president, Poland will adopt a more cryptocurrency-friendly approach. This would include friendlier regulations, lower taxes, and support from banks and regulatory agencies. 
&#8220;BTC to the Moon,&#8221; the presidential hopeful wrote, a slang phrase used by Bitcoin maximalists having strong conviction in the cryptocurrency&#8217;s upside potential.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Poland should create a Strategic Bitcoin Reserve. If I become the President of Poland, our country will become a cryptocurrency haven, with very friendly regulations, low taxes, and a supportive approach from banks and regulators. BTC to the Moon! <a href="https://t.co/izKc4spkkV">pic.twitter.com/izKc4spkkV</a>
&mdash; Sławomir Mentzen (@SlawomirMentzen) <a href="https://twitter.com/SlawomirMentzen/status/1858276016822603970?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Presidential elections in Poland are slated for May 2025. Mentzen belongs to the far-right libertarian party New Hope, which has just 8 seats in the Sejm, Poland's lower house of parliament. 
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42014985/matt-gaetz-to-be-confirmed-as-attorney-general-in-a-trump-administration-not-so-fast-polymarket-traders-say?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Matt Gaetz To Be Confirmed As Attorney General In A Trump Administration? Not So Fast, Polymarket Traders</a>
Why It Matters: Mentzen&#8217;s pledge is similar to that of U.S. President-elect Donald Trump, who made several such Bitcoin-supportive promises during his campaign, including <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40179714/trumps-bitcoin-stockpile-plan-would-have-positive-impact-on-crypto-prices-but-would-leave-">the establishment of a strategic Bitcoin stockpile</a>.
Since his electoral triumph, expectations of such a reserve have surged significantly. Senator Cynthia Lummis, who (R-Wyo.) proposed the legislation earlier in July, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784950/pro-bitcoin-senator-cynthia-lummis-vows-to-build-a-strategic-bitcoin-reserve-as-industry-e">reiterated her vow to establish the reserve</a>. If the bill is passed, it would create a Bitcoin fund to act as a hedge against the national debt. The bill aims to accumulate a million Bitcoins over a five-year period, which would be held for at least 20 years.
Apart from Trump, El Salvador President Nayib Bukele is <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41847581/el-salvadors-bitcoin-bet-is-paying-off-heres-how-much-the-country-is-up">globally renowned for introducing pro-Bitcoin policies</a> in his tenure, including recognition of the cryptocurrency as a legal tender. 
Price Action: At the time of writing, Bitcoin was exchanging hands at $91,779.08, up 1.50% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42028576/rfk-jr-stands-firm-on-bitcoin-as-currency-of-freedom-says-howard-lutnik-as-treasury-secretary-will-be-best-for-apex-crypto">Robert Kennedy Jr. Calls Bitcoin The &#8216;Currency of Freedom,&#8217; Backs Trump&#8217;s Treasury Secretary Pick As Best For Crypto</a></li>
</ul>
Photo courtesy: Pixabay

Politics

The Trump Playbook? Polish Presidential Candidate Mentzen Promises To Establish Bitcoin Reserve

<h3>Companies Reporting Before The Bell</h3>
• Niu Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is expected to report earnings for its third quarter. 
• Bit Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $22.91 million. 
• Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) is likely to report quarterly loss at $0.69 per share on revenue of $82.66 million. 
• Mondee Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOND#NASDAQ">MOND</a>) is likely to report quarterly loss at $0.10 per share on revenue of $54.49 million. 
• Brady (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) is projected to report quarterly earnings at $1.10 per share on revenue of $365.85 million. 
• Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) is expected to report quarterly loss at $0.05 per share on revenue of $77.45 million. 
• Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) is likely to report earnings for its third quarter. 
• Kandi Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is estimated to report earnings for its third quarter. 
• EHang Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>) is likely to report quarterly loss at $0.12 per share on revenue of $16.30 million. 
• C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) is projected to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is likely to report quarterly earnings at $0.91 per share on revenue of $2.20 billion. 
• Tuya (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $75.49 million. 
• BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) is estimated to report quarterly earnings at $0.50 per share on revenue of $545.01 million. 
• i3 Verticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IIIV#NASDAQ">IIIV</a>) is projected to report quarterly earnings at $0.19 per share on revenue of $61.55 million. 
• AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) is likely to report quarterly earnings at $1.25 per share on revenue of $4.12 billion. 
• Symbotic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $470.27 million. 
• Zenvia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) is estimated to report earnings for its third quarter. 
• TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report earnings for its third quarter. 
• FinVolution Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) is estimated to report earnings for its third quarter. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is estimated to report earnings for its third quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

BRBR

BTBT

BTDR

CISS

CLRB

FINV

IIIV

KNDI

MOND

TATT

TCOM

TUYA

TWST

ZENV

ZEPP

Earnings Scheduled For November 18, 2024

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced its industry-leading third-generation automotive TDDI IC, the HX83195 series, and automotive OLED touch controller IC, the HX8530 series, have commenced mass production in the third quarter. These new product launches highlight Himax's technological innovation capabilities, strengthen its market influence, solidify its leadership in the high-end automotive display market, and reaffirm its commitment to advancing automotive display technology. Himax holds a dominant position in the automotive LCD and OLED display markets, boasting industry-leading market share and the most comprehensive product portfolio in the industry.
HX83195 series third-generation Automotive TDDI pushes the limits of large-sized and high-resolution automotive displays, delivering an unparalleled touch experience
As the leader in the global automotive TDDI market, Himax boasts a more than 50% market share with accumulated TDDI shipments exceeding 70 million units to date, far surpassing those of its competitors. Driven by continuous innovation from the Company's engineering team, the third-generation TDDI HX83195 series has quickly become the preferred solution for automakers in Europe, the U.S., and Asia since its launch, and has been rapidly adopted in their latest vehicle designs. Zeekr, a high-end Chinese EV brand under the Geely group, became the first to adopt the HX83195 for its 16-inch, 3.2K x 2K high resolution in-cell touch display which began commenced mass production in the third quarter of the year.

HIMX

Himax Leads Automotive Display Market with New TDDI and OLED Touch Controllers, Ramps Up Mass Production

Nuclear energy stocks and ETFs have come to the fore as ARK Invest&#8217;s founder Cathie Wood <a href="https://www.ark-invest.com/articles/analyst-research/nuclear-energy-could-contribute-meaningfully-to-securing-net-zero-emissions">reshared the firm&#8217;s study </a>on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and rendered nuclear energy less cost-competitive than natural gas today.
This comes as Tesla Inc. and SpaceX CEO Elon Musk is all set to co-lead the Department of Government Efficiency (DOGE) along with Republican politician Vivek Ramaswamy. As the task force promises to dismantle bureaucracy, reduce regulations, and cut wasteful expenditures, ARKinvest tried to redirect DOGE&#8217;s official page on X (formerly Twitter) to focus on the regulatory hurdles that nuclear energy as a sector has faced in the last 20 years.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Resurfacing this chart amid all the <a href="https://twitter.com/DOGE?ref_src=twsrc%5Etfw">@DOGE</a> talk. U.S. nuclear construction costs declined in accordance with Wright's Law before being derailed by regulatory changes in the 1970s&#8230; Blog and sources: <a href="https://t.co/S2o84BkdA3">https://t.co/S2o84BkdA3</a> <a href="https://t.co/kES3g5Ph80">https://t.co/kES3g5Ph80</a> <a href="https://t.co/VBb6puiP5R">pic.twitter.com/VBb6puiP5R</a>
&mdash; Daniel Maguire (@DMaguireARK) <a href="https://twitter.com/DMaguireARK/status/1857163799037448601?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What Happened: &#8220;The International Energy Agency has identified nuclear energy as vital to achieving net zero emissions by 2050, yet nuclear power in the United States has stagnated at ~20% of the energy mix since the Chernobyl disaster in 1986,&#8221; said an ARKInvest note based on data from IEA as of October 2023.
In addition to its cost-effectiveness, nuclear power provides a reliable, continuous, and carbon-free supply of energy. These are important now since an explosion in demand for artificial intelligence is taxing the electricity consumption of data centers.
Also read: <a href="https://www.benzinga.com/politics/24/11/41962372/trumps-doge-with-musk-at-the-helm-riddled-with-conflicts-of-interest-says-clinton-era-official-robert-reich">Trump&#8217;s DOGE With Musk At The Helm &#8216;Riddled With Conflicts Of Interest&#8217; Says, Clinton-Era Official Robert Reich</a>
Daniel Maguire, research associate at ARKInvest stated in his report dated April 2024 that stringent regulatory changes and anti-nuclear sentiment have stunted the build-out of nuclear capacity and caused cost overruns in developing US nuclear plants.
Regulatory changes in the mid-to-late seventies, including the establishment of the Nuclear Regulatory Commission and the Energy Research and Development Administration, introduced stricter licensing measures, increasing costs significantly. Without such stringent regulations, ARKInvest&#8217;s research suggests that lower cost trajectories could have saved the US about $345 billion, or ~72% of the total.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="754" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014702/Nuclear-plan-costs-1024x754.png" alt="" class="wp-image-652244" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014702/Nuclear-plan-costs-1024x754.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014702/Nuclear-plan-costs-300x221.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014702/Nuclear-plan-costs-768x566.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014702/Nuclear-plan-costs.png 1466w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Why It Matters: With the introduction of the U.S. Advanced Reactor Demonstration Project and other emerging government support programs, nuclear cost overruns should reverse course as countries look for robust clean energy solutions to meet their net carbon emissions reduction commitments.
Maguire&#8217;s tweet shared by Wood, tagged the Department of Government Efficiency, to bring this to light. The department is scheduled to complete its work by July 4, 2026, coinciding with America's 250th independence anniversary. Focus on this area could help spur activity in the nuclear energy sector by developing clean, carbon-free energy production avenues at lower costs.
Also read: <a href="https://www.benzinga.com/government/regulations/24/11/42006530/tesla-ceo-and-doge-co-lead-elon-musk-says-excess-government-spending-causes-inflation-heres-what-experts-say">Tesla CEO And DOGE Co-Lead Elon Musk Says &#8216;Excess Government Spending&#8217; Causes Inflation: Here&#8217;s What Experts Say</a>
Price Action: Despite long-running regulatory hurdles and higher costs, nuclear energy stocks have performed well on a year-to-date basis. Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), Cameco Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>), Centrus Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>), NuScale Power Corp (SMR) and VanEck Uranium and Nuclear ETF (ACRA: NLR) have all outperformed NYSE composite on a year-to-date basis, which only rose by 16.65%.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="775" height="289" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014729/stock-list.png" alt="" class="wp-image-652245" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014729/stock-list.png 775w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014729/stock-list-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014729/stock-list-768x286.png 768w" sizes="(max-width: 775px) 100vw, 775px" /></figure>
The five-year charts as per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, show that Centrus Energy Corp shares have been volatile, whereas NuScale Power Corp has achieved consistent returns.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="271" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks-1024x271.png" alt="" class="wp-image-652246" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks-1024x271.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks-300x79.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks-768x203.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks-1536x406.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/18014753/nuclear-stocks.png 1741w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read next: <a href="https://www.benzinga.com/markets/24/11/42017638/activist-hedge-fund-valueact-boosts-meta-stake-with-121m-bet-but-ceo-morfit-supports-mark-zuckerberg">Activist Hedge Fund ValueAct Boosts Meta Stake With $121M Bet, But CEO Morfit Supports Mark Zuckerberg&#8217;s AI Vision: Here&#8217;s What Investors Should Know</a>
Image Via Shutterstock

Equities

OKLO

TLSA

Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed

Business Outlook
NIU expects revenues of the fourth quarter 2024 to be in the range of RMB 622 million to RMB 718 million, representing a year-over-year increase of 30% to 50%.

Guidance

Niu Technologies Expects Q4 Revenue Of RMB622M-RMB718M, Up By 30%-50%

The CNN Money Fear and Greed index showed a further decline in the overall market sentiment, with the index moving to the &#8220;Neutral&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones falling more than 300 points during the session. The S&amp;P 500 recorded a weekly loss of 2.1%, while the Nasdaq Composite fell around 3.2%. The 30-stock Dow lost 1.2% during the week.
Major tech stocks recorded losses, with Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares falling over 3% on Friday, and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) stock losing around 2.8% during the session. However, shares of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) gained around 3% on Friday.
Shares of vaccine companies settled lower on Friday after President-elect Trump nominated Robert F. Kennedy Jr. to lead the HHS. Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares dipped over 7%, while Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) shares declined more than 4% during the session. The SPDR S&amp;P Biotech ETF dipped over 5%, recording its worst week since 2020.
On the economic data front, U.S. export prices increased by 0.8% in October, while import prices rose by 0.3% month-over-month in October. U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, topping market estimates of 0.3%
Most sectors on the S&amp;P 500 closed on a negative note, with information technology, communication services, and healthcare stocks recording the biggest losses on Friday. However, utilities and financials stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 306 points to 43,444.99 on Friday. The S&amp;P 500 fell 1.32% to 5,870.62, while the Nasdaq Composite fell 2.24% at 18,680.12 during Friday's session.
Investors are awaiting earnings results from Trip.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>), Brady Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>), and AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 50.9, the index moved to the &#8220;Neutral&#8221; zone on Friday, versus a prior reading of 58.2.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

AMGN

MRNA

MSFT

NVDA

TSLA

Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone

Niu Technologies Q3 Adj EPADS $(0.06) Up From $(0.14) YoY, Sales $145.90M Vs $127.06M Estimate YoY

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk on Sunday acknowledged the need for bigger, family-sized electric vehicle models from the EV giant.
What Happened: &#8220;Ok,&#8221; Musk wrote to an X user who flagged the need for a bigger Tesla EV for bigger families. 
&#8220;We need big Teslas for big families,&#8221; the user wrote. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Ok
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1858341322496626750?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Tesla unveiled its dedicated <a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself">robotaxi offering called Cybercab</a> in October, featuring just two seats. Other Tesla vehicles come with five-seat interiors in the U.S., except the long-range all-wheel drive variant of Model Y in which Tesla offers a 7-seat interior option for an added $1,000 or $2,000, depending on the choice of color for the interiors.
Tesla also revealed a Robovan together with the two-seat Cybercab in October with no pedals or wheels capable of transporting up to 20 people or cargo without a driver. However, the company did not provide a production timeline for the vehicle. 
Why It Matters: Musk believes that a <a href="https://www.benzinga.com/news/24/06/39443823/elon-musk-once-said-collapsing-birth-rate-is-the-biggest-danger-civilization-faces-he-has-fathered-1">population collapse</a> is coming with people choosing to have fewer or no children. A population implosion will end civilization, he has previously said, urging people to have more children. 
In September, Reuters reported that Tesla is planning to produce a six-seat version of its&nbsp;<a href="https://www.benzinga.com/news/24/07/39659721/elon-musk-denies-rumors-of-model-y-refresh-yet-again-urges-fans-to-stop-speculating-over-fear-of-hur" target="_blank" rel="noreferrer noopener">Model Y SUV</a>&nbsp;starting next year in China.
The new variant of Tesla's best-selling vehicle will be made at the company's gigafactory in Shanghai starting late 2025, <a href="https://www.benzinga.com/news/24/09/40679900/tesla-plans-6-seat-model-y-production-in-china-starting-in-2025-report">Reuters reported</a>, citing two people familiar with the matter.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/24/11/42025066/elon-musks-spacex-delays-starship-test-flight-next-attempt-now-set-for-tuesday" target="_blank" rel="noreferrer noopener">Elon Musk's SpaceX Delays Starship Test Flight, Next Attempt Now Set For Tuesday</a></li>
</ul>
Photo courtesy: Tesla

Elon Musk Acknowledges X User's Call for Larger Tesla Models For Bigger Families

With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Brady Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRC#NYSE">BRC</a>) to report quarterly earnings at $1.10 per share on revenue of $365.88 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Brady shares rose 0.2% to $74.38 in after-hours trading.</li>
<li>Analysts expect AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) to post quarterly earnings at $1.24 per share on revenue of $4.14 billion. The company will release earnings after the markets close. AECOM shares gained 0.1% to $106.99 in after-hours trading.</li>
<li>IT Tech Packaging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITP#NYSE">ITP</a>) reported a loss of 20 cents per share for the third quarter, unchanged from the year-ago period. The company's sales jumped around 59% year-over-year to $25.08 million. IT Tech Packaging shares fell 0.6% to $0.2495 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Before the markets open, Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) is projected to report a quarterly loss at 10 cents per share on revenue of $78.85 million. Bitdeer Technologies shares gained 1.1% to $11.21 in after-hours trading.</li>
<li>Analysts expect Trip.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) to report quarterly earnings at 91 cents per share on revenue of $2.20 billion after the closing bell. Trip.com Group shares slipped 0.01% to $59.48 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Brady, Aecom And 3 Stocks To Watch Heading Into Monday

Global investment banks revealed significant positions held in cryptocurrency-related exchange-traded funds (ETFs) and Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) stock MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), according to their latest 13F filings with the SEC.
JPMorgan Chase
JPMorgan Chase &amp; Co., the world&#8217;s largest bank by market capitalization, made sizable investments in Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) ETFs for the quarter ending Sept. 30.
The bank purchased 387 shares, worth $13,982, of iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) after offloading them all in the last quarter.
JPMorgan also reallocated to Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>), bagging 213 shares worth $11,877. Overall, the banking giant's Bitcoin ETF exposure reached nearly $65,000.
JPMorgan tapped into the Ethereum ETFs for the first time, with sizable investments in Grayscale Ethereum Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETHE#NYSE">ETHE</a>) and its miniature version, Grayscale Ethereum Mini Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETH#NYSE">ETH</a>). Together, its stake in the two funds amounted to roughly $30,700.
The bid to increase cryptocurrency exposure caused JPMorgan to boost its MicroStrategy portfolio by 12.5% to 660,693 at the end of Q3, worth $111.39 million.&nbsp;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41873427/shiba-inu-lead-developer-shytoshi-kusama-pitches-s-h-i-b-in-response-to-elon-musks-call-for-new-roles-recommendations-in-trump-administration">Shiba Inu Lead Developer Shytoshi Kusama Pitches S.H.I.B In Response To Elon Musk&#8217;s Call For New Roles Recommendations In Trump Administration</a>
Goldman Sachs
Another Wall Street giant, Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), reported its 13F filing last week.
The bank <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42010782/goldman-sachs-expands-bitcoin-etf-holdings-to-710-million">disclosed </a>$710 million invested across multiple Bitcoin ETFs, with a stake of 12.7 million shares valued at $461 million in IBIT.&nbsp;
These investments solidified Goldman&#8217;s position as the second-largest holder of IBIT, now the world's biggest Bitcoin investment fund, with assets worth $42.89 billion as of this writing.&nbsp;
Goldman Sachs holds $25.16 million in Ethereum ETFs, split between Grayscale&#8217;s Mini Trust and Fidelity&#8217;s Ethereum Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FETH#BATS">FETH</a>).
Interestingly, the banking juggernaut liquidated around 534,894 shares of MicroStrategy in Q3, reducing its stake to $140.44 million.
Morgan Stanley
Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) downsized its Bitcoin ETF portfolio to $183.39 million, from $203 million in the <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40410418/goldman-sachs-makes-blockbuster-debut-adds-over-400m-in-bitcoin-etf-position-in-q2-as-morg">last quarter.</a> 
The outflows were primarily driven by the selling of 449,802 IBIT shares.
Additionally, Morgan Stanley invested in Ethereum ETFs, primarily through a stake in iShares Ethereum Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETHA#NASDAQ">ETHA</a>).
Meanwhile, its MicroStrategy position jumped 22.6% to 9,595,008 shares worth $1.61 billion. 
Photo by Avi Rozen on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42027183/michael-saylor-predicts-bitcoin-boom-says-100k-on-the-horizon">Michael Saylor Predicts Bitcoin Boom, Says $100K On The Horizon</a></li>
</ul>

ETHA

ETHE

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

IBIT

MSTR

Wall Street's Banking Giants Load Up On Bitcoin, Ethereum ETFs: Here's What JPMorgan, Goldman Sachs And Morgan Stanley Hold

PROC

Reported Friday, Procaps Faces Nasdaq Delisting Threat Due To Form 20-F Filing Delay, Seeks Hearing And Stay To Avoid Suspension

A prominent Wall Street analyst has reported a milestone for Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Full Self-Driving technology, completing an unassisted journey from Manhattan to Connecticut, marking a notable advancement in the <a href="https://www.benzinga.com/news/global/24/11/42028323/gary-black-defends-tesla-strategy-amid-clash-with-elon-musk-bulls-we-dont-trade-tesla-we-trim-when-the-price-goes-higher">company&#8217;s autonomous driving capabilities</a>.
What Happened: Pierre Ferragu, an analyst at New Street Research, shared his experience on X, formerly Twitter, stating, &#8220;Last night FSD got me out of deep into Manhattan and drove me back home to Connecticut. Got through a number of challenging and confusing situations with mastery. Not a single intervention. Robotaxi never felt that close ever before.&#8221;
For context, the drive from Manhattan to Connecticut spans approximately 94.7 miles and typically takes up to 1 hour and 45 minutes.
The successful navigation of complex urban environments represents a significant step forward for Tesla&#8217;s autonomous driving technology, particularly in challenging city conditions where s<a href="https://www.benzinga.com/news/24/09/41047267/safety-disaster-tesla-fsd-galaxies-away-from-being-anywhere-close-to-competition-says-bearish-analys">elf-driving systems typically face their greatest tests</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Last night FSD got me out of deep into Manhattan and drove me back home to Connecticut. Got through a number of challenging and confusing situation with mastery. Not a single intervention. Robotaxi never felt that close ever before…
&mdash; Pierre Ferragu (@p_ferragu) <a href="https://twitter.com/p_ferragu/status/1858138037009424474?ref_src=twsrc%5Etfw">November 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This development comes as Tesla continues to enhance its FSD technology amid growing competition in the autonomous vehicle sector from companies like Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)-backed Waymo, Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) and Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>). 
See Also: <a href="https://www.benzinga.com/24/11/42028342/blackwell-backfires-nvidias-ai-chips-struggle-with-server-overheating-impacting-meta-microsoft-and-musks-xai-data-centers">Nvidia&#8217;s Blackwell Chips Are Extra Toasty, Server Overheating Issues Impact Meta, Microsoft And Elon Musk&#8217;s xAI</a>
Why It Matters: The achievement is particularly notable given New York City&#8217;s demanding driving environment, known for its dense traffic, complex intersections, and unpredictable pedestrian movements.
Tesla&#8217;s autonomous driving progress comes at a crucial time as reports suggest a potential easing of federal regulations for self-driving vehicles, which could <a href="https://www.benzinga.com/markets/equities/24/11/42028797/tesla-soars-over-5-in-overnight-trading-as-trump-administration-reportedly-seeks-to-ease-fsd-norms">accelerate the company&#8217;s robotaxi ambitions</a>.
The stock has shown significant volatility over the past year, trading between $138.80 and $358.64, as investors weigh the company&#8217;s autonomous driving progress against market challenges, including changes to the federal EV tax credit structure.
Price Action: Tesla stock closed at $320.72 on Friday, gaining 3.07% for the day. In after-hours trading, the stock edged up 0.0062%. Year to date, Tesla's stock has risen by 29.10%, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42028523/cathie-wood-draws-reagan-era-parallels-as-elon-musk-takes-doge-helm-this-bull-market-has-just-begun-to-broaden-out">Cathie Wood Draws Reagan-Era Parallels As Elon Musk Takes DOGE Helm: &#8216;This Bull Market Has Just Begun To Broaden Out&#8217;</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BIDU

GOOG

GOOGL

MBLY

Pierre Ferragu Says 'Robotaxi Never Felt That Close Ever Before' After Tesla Drove Through Challenging Roads With No Intervention

Elon Musk has predicted that AI will surpass doctors and lawyers after a study revealed OpenAI&#8217;s ChatGPT-4 outperformed medical professionals in diagnosing illnesses.
What Happened: A study <a href="https://www.nytimes.com/2024/11/17/health/chatgpt-ai-doctors-diagnosis.html">reported</a> by&nbsp;The New York Times&nbsp;revealed that AI achieved a 90% accuracy rate, compared to 76% for doctors using ChatGPT as a tool and 74% for doctors relying on traditional resources.
Following the publication of the report, Bindu Reddy, CEO of Abacus.AI, stated that an AI doctor with access to all lab reports would be able to diagnose problems and&nbsp;suggest remedies better than most&nbsp;human doctors.
See Also:&nbsp;<a href="https://www.benzinga.com/tech/24/11/41932289/ai-capabilities-plateauing-say-andreessen-horowitz-founders-echoing-concerns-of-openai-co-founder-ilya-sutskever?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">AI Capabilities Plateauing, Say Andreessen Horowitz Founders, Echoing Concerns Of OpenAI Co-Founder Ilya Sutskever</a>
She added that the same would be true for lawyers and other knowledge-heavy professions.
Musk agreed with Reddy&#8217;s prediction, stating,&nbsp;&#8220;We can&nbsp;serve as a biological backstop&nbsp;for intelligence, as we are&nbsp;less brittle than silicon, and&nbsp;perhaps as a source of&nbsp;will.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">AI will soon beat doctors and lawyers by a large margin (and eventually all humans at almost everything). We can serve as a biological backstop for intelligence, as we are less brittle than silicon, and perhaps as a source of will.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1858305249783755206?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Last month, while speaking with Dr. Peter H. Diamandis, founder and executive chairman of the&nbsp;XPRIZE Foundation, Musk predicted that AI could <a href="https://www.benzinga.com/news/24/10/41618261/elon-musk-predicts-ai-will-match-human-capabilities-in-few-years-the-cup-is-80-full-maybe-90">reach human-level capabilities by 2029</a>.
Previously, the tech mogul has also said&nbsp;that the <a href="https://www.benzinga.com/news/24/06/39246781/elon-musk-thinks-humanoid-robots-will-one-day-exceed-human-population-from-nvidias-project-gr00t-to">number of humanoid robots</a> will one day exceed the human population.
&#8220;I think, long-term… the ratio of humanoid robots will be more than one-to-one. So, there probably might be two humanoid robots, or more, maybe 10, for every one human,&#8221; he earlier this year.
Earlier, Roman Yampolskiy, an AI safety researcher, also said that Musk&#8217;s company Neuralink, which aims to merge <a href="https://www.benzinga.com/news/24/06/39138007/elon-musks-neuralink-incredible-technology-can-make-humans-superhuman-says-ai-expert-but-warns-of-fu">human brains with Artificial General Intelligence</a> (AGI), could potentially make humans obsolete.
Image via Shutterstock
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/retail-sales/24/11/42024288/consumer-tech-news-november-11-15-apple-plans-to-launch-an-ai-wall-tablet-meta-plans-to-introduce-ads-on-threads-more?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Consumer Tech News (November 11-15): Apple Plans To Launch An AI Wall Tablet, Meta Plans To Introduce Ads On Threads &amp; More</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Elon Musk Says AI Will Surpass Doctors, Lawyers After ChatGPT Tops Medical Diagnoses — Humans Becoming 'Biological' Backups

Dell Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) has reached a major milestone by becoming the first company to deliver a new generation of super-powerful computer systems designed specifically for artificial intelligence.
What Happened: Michael Dell, the company&#8217;s CEO, announced on social media platform X that Dell is shipping its first liquid-cooled PowerEdge XE9712 systems to CoreWeave, a company that provides computing power for AI applications.
&#8220;The AI rocket just got a massive boost!&#8221; Michael Dell in his announcement, highlighted the significance of this achievement.
These new systems, developed in partnership with tech giant NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), are unlike traditional computers. They use special cooling technology that helps them handle the intense processing needed for advanced AI tasks. Think of it as the difference between a regular car engine and a Formula 1 racing engine – both are engines, but one is designed for much more powerful performance.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The 1st in the world <a href="https://twitter.com/nvidia?ref_src=twsrc%5Etfw">@nvidia</a> GB200 NVL72 server racks are now shipping. We are thrilled to deliver our liquid-cooled PowerEdge XE9712 to <a href="https://twitter.com/CoreWeave?ref_src=twsrc%5Etfw">@CoreWeave</a>. The AI rocket just got a massive boost! &#x1f916;&#x1f680;&#x1f91d; <a href="https://t.co/2QzlxbQE5f">pic.twitter.com/2QzlxbQE5f</a>
&mdash; Michael Dell (@MichaelDell) <a href="https://twitter.com/MichaelDell/status/1858306164775379268?ref_src=twsrc%5Etfw">November 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/24/11/42028954/peter-thiel-says-trumps-60-china-tariff-would-be-very-very-bad-for-beijing-heres-whats-at-stake">Peter Thiel Says Trump&#8217;s 60% China Tariff Would Be &#8216;Very, Very Bad&#8217; For Beijing, Here&#8217;s What&#8217;s At Stake</a>
Why It Matters: The system, called the GB200 NVL72, combines 72 powerful processing chips (GPUs) and 36 central computers (CPUs) working together as one unit. This allows it to run AI programs 30 times faster than previous systems, particularly when handling complex AI tasks like chatbots and image generation.
CoreWeave, the company receiving these first systems, specializes in providing high-powered computing services to businesses working with AI. They work closely with Nvidia, which designed the core technology inside these systems.
This development is particularly important as companies worldwide are racing to build and access more powerful AI computing systems. Industry experts predict high demand for these systems, with <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39168191/nvidia-maintains-lead-as-key-ai-beneficiary-analyst-boosts-estimates-after-taiwan-e">estimates suggesting 20,000 to 25,000 similar systems could be shipped in 2025</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42028523/cathie-wood-draws-reagan-era-parallels-as-elon-musk-takes-doge-helm-this-bull-market-has-just-begun-to-broaden-out">Cathie Wood Draws Reagan-Era Parallels As Elon Musk Takes DOGE Helm: &#8216;This Bull Market Has Just Begun To Broaden Out&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

DELL

Dell Ships First 72-Nvidia GPU Monster: 'AI Rocket Just Got A Massive Boost,' Says CEO

<ul>
<li>Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of Life</li>
<li>New Data from FOREST-HCM Demonstrate Aficamten Durably Reduces the Proportion of Patients Guideline Eligible for Septal Reduction Therapy</li>
<li>Analyses of Real-World Data Reveal Cost of Care Differences in HCM&nbsp;Across Gender, Age and Race/Ethnicity</li>
</ul>

CYTK

Reported Saturday, Cytokinetics Unveils New Data On Aficamten And Hypertrophic Cardiomyopathy At AHA Scientific Sessions 2024

Cytokinetics, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) today announced new data from post-hoc analyses of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 cardiovascular outcomes clinical trial of omecamtiv mecarbil were presented at the American Heart Association Scientific Sessions 2024 in Chicago, IL.
"These analyses reinforce the potential treatment benefit of omecamtiv mecarbil in patients from GALACTIC-HF who are at higher risk, such as older patients or those with a recent ventricular arrhythmia," said Stuart Kupfer, M.D., Senior Vice President, Chief Medical Officer. "As we prepare for the start of COMET-HF, the confirmatory Phase 3 clinical trial of omecamtiv mecarbil, we look forward to evaluating its potential to reduce the risk of adverse heart failure outcomes across the spectrum of these very high-risk patients failing guideline-directed medical therapy."

Reported Saturday, Cytokinetics Shares Additional GALACTIC-HF Insights At AHA 2024

-Data demonstrate characteristics essential for treatment of autoimmune diseases, including robust tissue homing and complete CD19+ B cell depletion in secondary lymphoid tissue
-Results highlight the potential benefits unique to gamma delta 1 CAR T cell therapy and ADI-001's potential as a best-in-class off-the-shelf cell therapy for autoimmune diseases
-The company is pursuing ADI-001 in a basket study across six indications including lupus nephritis (LN), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), idiopathic inflammatory myopathy (IIM), stiff person syndrome (SPS) and anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV)

ACET

Reported Saturday, Adicet Bio Shared Clinical Biomarker Data On Off-The-Shelf CAR T Cell Therapy During Oral Session At ACR Convergence 2024

<ul>
<li>In a first-of-its-kind study, tirzepatide also alleviated heart failure symptoms and physical limitations</li>
<li>Patients on tirzepatide experienced improved exercise capacity, greater weight loss and reduced systemic inflammation</li>
<li>Lilly has initiated submissions for tirzepatide for the treatment of HFpEF and obesity to global regulatory agencies</li>
</ul>

Reported Saturday, Eli Lilly's Tirzepatide Cuts Heart Failure Risk By 38% In Adults With Heart Failure With Preserved Ejection Fraction (HFpEF) And Obesity

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), ACADIA Pharmaceutic...

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), ACADIA Pharmaceuticals (ACAD)

Leerink Partners analyst David Risinger has reiterated their bullish stance on CNTA stock, giving a Buy rating yesterday. David Risinger's rating i...

Centessa Pharmaceuticals' ORX142 Shows Promising Preclinical Results and Market Potential

Centessa Pharmaceuticals GAAP EPS of -$0.37

Centessa Pharmaceuticals ( ($CNTA) ) has shared an update. Centessa Pharmaceuticals is making strides with its OX2R agonist program, showcasing pro...

Centessa Pharmaceuticals Advances Pipeline with Promising OX2R Data

Analyst Mayank Mamtani from B.Riley Financial maintained a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report) and keeping the price ta...

Centessa Pharmaceuticals: Promising Pipeline and Strategic Focus Drive Buy Rating

Centessa Pharmaceuticals Plc ( ($CNTA) ) has released its Q3 earnings. Here is a breakdown of the information Centessa Pharmaceuticals Plc presente...

Centessa Pharmaceuticals Strengthens Financial Position Amid Losses

In a report released today, Kostas Biliouris from BMO Capital assigned a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report), with a pr...

Centessa Pharmaceuticals' ORX750: Promising Efficacy and Strategic Positioning Reinforce Buy Rating

BofA raised the firm's price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the...

Alkermes price target raised to $31 from $28 at BofA

Leerink Partners analyst David Risinger has reiterated their bullish stance on CNTA stock, giving a Buy rating yesterday. David Risinger has given ...

Buy Rating for Centessa Pharmaceuticals: Promising Orexin Program and Strategic Portfolio Advances

Guggenheim raised the firm's price target on Centessa (CNTA) to $28 from $24 and keeps a Buy rating on the shares after the company "pre-empted the...

Centessa price target raised to $28 from $24 at Guggenheim

ABBV

ACAD

ALKS

CNTA

Management

Press Releases

Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer

Health Care

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual  Global Healthcare Conference

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Financing

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Comments

Centessa Pharmaceuticals

Vendite allo scoperto

Centessa Pharmaceuticals (NASDAQ:CNTA) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO